When was R-Zero founded?

R-Zero was founded in 2020 and raised its 1st funding round within a year of its incorporation.

Where is R-Zero located?

R-Zero is headquartered in San Francisco, United States.

How many employees does R-Zero have?

As of Mar 31, 2026, the latest employee count at R-Zero is 63.

Is R-Zero a funded company?

R-Zero is a funded company, having raised a total of $170M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Sep 11, 2020.

How much is R-Zero worth?

The latest valuation of R-Zero is $***** as of Jul 21, 2021.

When was the latest funding round of R-Zero?

R-Zero's latest funding was a $***** Series C round on May 25, 2022, with participation from 9 investors.

Where does R-Zero rank among its competitors?

R-Zero ranks 1st amongst 84 active competitors, of which 17 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Aquisense, which secured $2.5M in Mar, 2025.

Who are the top competitors of R-Zero?

R-Zero's top competitors include Germitec, Aquisense and Crystal IS. Among them, Aquisense secured the most recent funding round in March, 2025.

R-Zero - 2026 Company Profile, Team, Funding & Competitors

R-Zero is a series C company based in San Francisco (United States), founded in 2020 by Ben Boyer, Eli Harris and Grant Morgan. It operates as a Developer of UV-C disinfection devices for hospital infection control. R-Zero has raised $170M in funding from investors like World Innovation Lab, DBL Partners and Upfront Ventures, with a current valuation of $*****. The company has 84 active competitors, including 17 funded and 7 that have exited. Its top competitors include companies like Germitec, Aquisense and Crystal IS.

Company Details

Developer of UV-C disinfection devices for hospital infection control. It has developed an R-Zero Arc device that destroys pathogens & infectious reagents. The device is designed for hospitals and that can kills pathogens like SARS-COV-2, MRSA, and E.Coli. It can be used for disinfecting air, water, surfaces to kill bacteria, viruses, molds, and a whole host of human pathogens by disrupting the molecular bonds of their DNA and RNA.

Website: rzero.com
Social
Email ID: *****@rzerosystems.com

Key Metrics

Founded Year

2020

Location

San Francisco, United States

Stage

Series C

Total Funding

$170M in 3 rounds

Latest Funding Round

Series C, May 25, 2022, $*****

Post Money Valuation

$***** as on Jul 21, 2021

Investors

World Innovation Lab & 12 more

Ranked

1^st among 84 active competitors

Employee Count

63 as on Mar 31, 2026

Investment & Acquisitions

SecureAire & 1 more

Similar Companies

Germitec & 120 more

View R-Zero's full profile

R-Zero has raised a total funding of $170M over 3 rounds. Its first funding round was on Sep 11, 2020. Its latest funding round was a Series C round on May 25, 2022 for $*****. 9 investors participated in its latest round. R-Zero has 12 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of R-Zero:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 25, 2022	3917146	Series C	8685214	6476024	3923663	4805527
Jun 16, 2021	9169224	Series B	7837202	4016616	8488489	John Doerr & 2 more
Sep 11, 2020	1890413	Series A	5526750	8214547	DBL Partners	Bedrock & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of R-Zero's funding rounds and investors

The founders of R-Zero are Ben Boyer, Eli Harris and Grant Morgan.

Here are the details of R-Zero's key team members:

Ben Boyer: Co-Founder of R-Zero and founder of 2 other companies, Tenaya Capital and Tenaya Capital. They are also an angel investor in 3 startups and serve on the board of 1 company.
Contact Info: 1 phone number
Eli Harris: Former Co-Founder of R-Zero and founder of 1 other company.
Grant Morgan: Former Co-Founder of R-Zero.

View details of R-Zero's Founder profiles and Board Members

R-Zero's employee count trend

R-Zero has 63 employees as of Mar 26. Here is R-Zero's employee count trend over the years:

Uncover R-Zero's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of R-Zero include Germitec, Aquisense and Crystal IS. Here is the list of Top 10 competitors of R-Zero, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	R-Zero 2020, San Francisco (United States), Series C	Developer of UV-C disinfection devices for hospital infection control	$170M	Qualcomm Ventures, Mayo Clinic & 11 others	64/100
2nd	Germitec 2005, Bordeaux (France), Series B	Provider of UV-C high-level disinfection systems for ultrasound probes. These systems offer automated, fast, safe, and environmentally friendly disinfection for endocavitary and external ultrasound probes. The technology utilizes UV-C light to kill bacteria, fungi, viruses, mycobacteria, and spores, improving standards of care by reducing cross-contamination risk. The systems are designed to optimize workflow and enhance traceability, ensuring quality of care. The chemical-free solution contributes to a safer and more sustainable healthcare environment.	$41.6M	Eurazeo, Sham & 5 others	54/100
3rd	Aquisense 2015, Erlanger (United States), Acquired	Provider of UV-C LED based disinfection system	$2.5M	Burnt Island, Black Cliffs Partners	51/100
4th	Crystal IS 1997, Albany (United States), Acquired	Manufacturer of aluminum nitride UVC LEDs and related disinfection systems	$15.2M	Lux Capital, Credit Suisse & 6 others	50/100
5th	Violet Defense 2012, Celebration (United States), Series B	Provider of Ultra-Violet cleaning and disinfecting solutions	$34.2M	Kirenaga Partners, Katalyst Securities	47/100
6th	UV Partners 2004, Wyoming (United States), Series A	Provider of UV-based air sterilization device for hospitals and healthcare industries	$20.5M	Pallas Advisors, Michigan Rise & 2 others	43/100
7th	Aerobiotix 2013, Ohio (United States), Series A	Provider of UV-based disinfection systems for hospitals and other establishments	$25M	Vivo Capital, Asahi Kasei	40/100
8th	Vyv 2012, Latham (United States), Series A	Provider of antimicrobial LED light to kill infectious pathogens	$3.35M	Belle Capital USA, Citi Ventures & 11 others	36/100
9th	Strl Bio 2020, Hyderabad (India), Seed	Provider of air disinfection systems for hospitals and healthcare institutions	$11.6K	AIC-CCMB	36/100
10th	Alfaa UV 2004, Mumbai (India), Unfunded	UV air & water purification systems	-	-	36/100